(Q37861450)
Statements
Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma (English)
J Randolph Hecht
Pierre Major
Elke Jäger
Robert A Wolff
Katherine Lloyd-Salvant
Kelly Pendergrass
William Berg
Bee-Lian Chen
Tarja Jalava
Gerold Meinhardt
Dirk Laurent
David Lebwohl
David Kerr
John D Hainsworth